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ScienceDirectAll types of cellular RNAs are post-transcriptionally modified,
constituting the so called ‘epitranscriptome’. In particular,
tRNAs and their anticodon stem loops represent major
modification hotspots. The attachment of small chemical
groups at the heart of the ribosomal decoding machinery can
directly affect translational rates, reading frame maintenance,
co-translational folding dynamics and overall proteome
stability. The variety of tRNA modification patterns is driven by
the activity of specialized tRNA modifiers and large
modification complexes. Notably, the absence or dysfunction
of these cellular machines is correlated with several human
pathophysiologies. In this review, we aim to highlight the most
recent scientific progress and summarize currently available
structural information of the most prominent eukaryotic tRNA
modifiers.
Addresses
1Max Planck Research Group at the Malopolska Centre of
Biotechnology, Jagiellonian University, Krakow, Poland
2Department of Cell Biochemistry, Faculty of Biochemistry, Biophysics
and Biotechnology, Jagiellonian University, Poland
3Postgraduate School of Molecular Medicine, Warsaw, Poland
Corresponding author: Glatt, Sebastian (sebastian.glatt@uj.edu.pl)
4 These authors contributed equally.
Current Opinion in Structural Biology 2019, 55:138–146
This review comes from a themed issue on Macromolecular
assemblies
Edited by Ilya A Vakser and Andrzej Joachimiak
For a complete overview see the Issue and the Editorial
Available online 16th May 2019
https://doi.org/10.1016/j.sbi.2019.03.014
0959-440X/ã 2019 The Authors. Published by Elsevier Ltd. This is an
open access article under the CC BY-NC-ND license (http://creative-
commons.org/licenses/by-nc-nd/4.0/).
Introduction
The ‘Modomics’ database for RNA modification [1] cur-
rently lists 200 unique chemical modifications of RNA,
with around half of them being detected in tRNAs of all
known species [2–4]. Despite their strong sequence vari-
ation, all cellular tRNAs need to fold into almost identical
three-dimensional structures to fit the relatively narrow
tRNA binding sites of the ribosome during translation
elongation. The possibility of incorporating chemical
groups, which contribute additional biophysical proper-
ties to the individual RNA bases, vastly expands the range
of suitable sequences that can fold into the characteristic
L-shaped tRNA structure. In addition, the modificationCurrent Opinion in Structural Biology 2019, 55:138–146 of RNA bases in and around the anticodon impacts on
their intrinsic geometry and canonical Watson–Crick base
pair interactions between codons and anticodons [5–7].
These alterations strongly influence the dynamics of
tRNA selection at the ribosomal A-site [8] and subse-
quently affect the local elongation speed, co-translational
folding dynamics [9], proteome stability and cell survival
[10]. tRNA modifications were initially thought to be
routinely and uniformly added to their respective tRNA
molecules. To date, it is becoming increasingly clear that
most of them are dynamically regulated in response to
environmental cues [11,12] and an intense cross talk
between various modifications and their pathways
emerges [13]. Here, we aim to provide a comprehensive
summary of the respective modification enzymes that
produce this plethora of posttranscriptional modifications
patterns. We summarize available structural and func-
tional knowledge concerning the most abundant families
of tRNA modification enzymes. Our focus lies on the
main modification cascades and known macromolecular
assemblies that target the ASL in eukaryotes (Figure 1).
These partially highly complex molecular machines are
not only important guardians of the proteome and regu-
latory factors of translational elongation, but are also
clinically very important. The pathophysiological conse-
quences and clinical implications of disease-causing
mutations in tRNA modifiers are very well covered by
recent expert reviews [14–17].
(t)RNA methyltransferases
Methylations affect multiple properties of tRNA mole-
cules, including folding dynamics, thermostability, mat-
uration as well as protection from cleavage or priming for
the synthesis of subsequent modifications [18,19].
Eukaryotic tRNA methyltransferases (TRMs) typically
utilize S-adenosyl methionine (SAM) as a methyl group
donor which results in formation of a S-adenosyl-L-
homocysteine and a methylated product [20]. In the
following section, we aim to highlight structurally char-
acterized TRMs and describe their selectivity for certain
tRNA species and specific base positions within the
respective ASLs (Figure 2).
In detail, Trm1, which conducts a double methylation of
the exocyclic nitrogen of G26, which promotes a proper
folding of multiple tRNA species by enforcing a water-
mediated interaction of m2
2G26 with a nearby cytosine
[21,22]. In yeast, Trm140 binds tRNASer and tRNAThr
and catalyzes m3C32 in a i
6A37-dependent manner [23].
In human, Trm140 functionally corresponds to thewww.sciencedirect.com
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tRNA modifications occurring within the tRNA anticodon region.
Overview of the tRNA anticodon loop in cartoon representation. Individual modifications are grouped, highlighted, and labeled. Respectively from
the left methylation (indigo), modification of position 34 (violet), 5-carboxymethyluridin (light green), pseudouridylation (rose), thiolation (yellow),
wybutosine (yW; blue) N6-isopentenyladenosine (i6A) and N6-threonylcarbamoyladenosine (t6A) (red), adenine deamination (teal). Modifications
occurring within anticodon region are plotted and highlighted on a model tRNAGlu (PDB ID 2CV2).Methyltransferase-like (Mettl) 2, 6 and 8 proteins [24,25].
Although Mettl2/6/8 are currently not structurally charac-
terized, structures of the Mettl3/Mettl14 complex that
provides N6-adenosine methylation [26–28] and the
methyltransferase domain of Mettl16 [29] provide new
insights into the METTL protein family. The known
structure of human Ftsj2, a homolog of yeast Trm7,
reveals a typical class I TRM fold [18]. In yeast, 20-O
ribose methylation provided by Trm7 is guided by its
interactions with Trm732 and Trm734, which drive the
reactions at positions 32 and 34, respectively [30]. Trm4
catalyzes modifications at positions m5C48 and m
5C49;
however, it is also capable of generating m5C34 and
m5C40 [31]. Archaeal Trm4 was co-crystalized in the
presence of a naturally occurring inhibitor sinefungin
[32]. In human, Trm4 has two functional counterparts,
Nsun2 and Nsun3 catalyzing m5 modifications in the
nucleus and mitochondria, respectively. In addition to
its tRNA modification activity, Nsun2 was reported to
methylate miRNAs [33]. Methylation of the wobble
cytosine provided by Nsun3 is required for initiation of
5-formylcytidine (f5C34) synthesis on tRNA
Met [34]. The
first known structure of Nsun family member was solvedwww.sciencedirect.com for Nsun6, which catalyzes the m5C72 modification [35
].
Trm5 is another multifunctional enzyme, capable of con-
ducting m1 modification at G37 or I37. Interestingly, Trm5
also plays a role in some archaeal species during wybutosine
(yW37) synthesis. Trm5 was co-crystalized with tRNA
Phe
and a SAM cleavage product [36]. Available structure
elucidates both the Trm5-tRNA interaction and the moon-
lightingactivityofTrm5 inarchaea [36].Anothermember
of the class Dnmt2, historically considered a DNA-specific
methyltransferase [37], provides a m5C tRNA modification
at C38 and C40 [38]. m
5C38was demonstrated to prevent the
generation of tRNA-derived fragments [39], which appear
due to the tRNA cleavage under stress conditions and may
act as regulatory RNAs [40]. Although available structures
do not provide an explicit explanation for tRNA recogni-
tion, the enzymatic activity of a fungal Dnmt2 was recently
found to be stimulated by the presence of queuosine [41].
Pseudouridine synthases
Pseudouridylation is one of the most widely spread mod-
ification in all types of RNAs, including tRNAs, snRNAs,
rRNA, ncRNAs, and mRNAs, and occurs in each domain
of life [42]. This altered form of a uridine base arisesCurrent Opinion in Structural Biology 2019, 55:138–146
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Figure 2
Mettl3 • Mettl14 Trm1 (Trmt1) Dnmt2 (M.HsaIIP)
Trm5 (Trmt5)
CTD
RRMRRMCTM
Mettl3 Mettl14
Ftsj2 (Trm7)
Trm4 (Ncl1, Nsun2) Trm9 • Trm112 Abh8RRM
RRM
RRM
Trm9 Trm112
AlkB-like
Trm9-like
domain
m22G26
m5C40
m5C38
m5C37
m3C32
Nm32
m5C34 mcm5U34 mchm5U34
Mettl2,6,8
Current Opinion in Structural Biology
Structural overview of methyltransferases acting on the ASL of tRNA.
tRNA methyltransferases share a structurally similar TRM domain (dark blue) and an RNA recognition motif (RRM, orange). Ligands and relevant
active site residues are highlighted in yellow. Names, alternative names or names of close homologs are shown in parentheses. Trm1 from
Pyrococcus horikoshii co-crystalized with a SAM molecule (PDB ID 2EJT). Human Mettl3-Mettl14 complex co-crystalized with SAM (PDB ID 5IL1).
Human Ftsj2, a Trm7 homolog, co-crystalized with SAM (PDB ID 2NYU). Trm4 from Methanocaldococcus jannaschii crystalized with an inhibitor
(PDB ID 3A4T). Trm9–Trm112 complex from Yarrowia lipolytica. Trm9 is shown in blue, Trm112 (grey) activates the catalytic subunit (PDB ID
5CM2). N-terminal part of a human Abh8, which consists an AlkB-like domain (green) and a Trm9-like domain missing from the structure (PDB ID
3THP). Trm5 from Pyrococcus abyssi co-crystalized with a SAM degradation product and a tRNAPhe (PDB ID 5WT3). Human Dnmt2 co-crystalized
with SAH (PDB ID 1G55).through the substitution of the canonical carbon-nitrogen
glycosidic bond (C1–N1) with a carbon-carbon bond (C1–
C5) between the ribose and uracil. This simple isomeri-
zation reaction is conducted by stand-alone enzymes
called pseudouridine synthases (PUS). Interestingly, pro-
karyotic and eukaryotic members of the five PUS fami-
lies, namely TruA, TruB, TruD, RsuA, and RluA, display
relatively low sequence identity, but show very similar
folds of the catalytic domain [43,44]. The conserved
core of PUS enzymes is created by a central eight-
stranded b-sheet and several surrounding helices, which
properly position the catalytically active aspartate residue
in proximity to the uridine base of the respective targetCurrent Opinion in Structural Biology 2019, 55:138–146 RNA. In the ASL of various eukaryotic tRNAs, several
positions, namely U27, U28, U30, U31, U32, U34, U35, U36,
U38, and U39, are specifically converted into pseudour-
idine. PUS enzymes are found in the nucleus, the cyto-
plasm, and mitochondria and for tRNA targets can be
divided into two major groups, namely modifiers of cyto-
plasmic or mitochondrial tRNAs.
In yeast, Pus1 is the main player for cytoplasmic tRNA
ASL modifications, which displays broad specificity for
target uridines (U26, U27, U28, U34, U35, U36) [45]. Pus7
shows specific activity at U35 and Pus8 appears as a highly
specific enzyme for U32 bases. Additionally, Pus3 andwww.sciencedirect.com
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mitochondrial tRNAs. The last two pseudouridine
synthases involved in anticodon modifications are Pus2
and Pus9, which are responsible for editing uridine in
mitochondrial tRNAs at U26/27 and U32 bases [42]. Strik-
ingly, Pus enzymes modify the anticodon bases in cyto-
plasmic tRNAs, whereas they don’t edit this important
decoding region in mitochondrial tRNAs. In humans,
TRUB2, RPUSD3, RPUSD4, and Pus1 have been pre-
dicted to target mitochondrial tRNAs, but only Pus1 has
been experimentally confirmed to modify mitochondrial
tRNAs, at positions 27 and 28 [46]. The other three
human mitochondrial pseudouridine synthases are less
well characterized [47], but have been proposed to modify
positions 31 and 32 [48] or 39 in mt-tRNAPhe [49]. Stand-
alone pseudouridine synthases have broad range of activ-
ity, lack of which leads to reduced growth in yeast
cells and major human diseases such as mitochondrial
myopathy, sideroblastic anemia (MLASA), or intellectual
disabilities [50,51].
The KEOPS complex
The bases in position 37 are highly modified in eukaryotic
tRNAs. Besides previously described methylation, the
formation of N6-isopentenyladenosine (i6A), N6-Figure 3
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www.sciencedirect.com threonylcarbamoyladenosine (t6A), wybutosine (yW) as
well as thiolation can be distinguished. The tRNA isopen-
tenyl transferases (IPTases) are responsible for i6A,
whereas yW is catalyzed by the concerted action of
Trm5 [36] and Tyw1-4, which are able to conduct
SAM-dependent methyl-transfer reactions [52,53]. t6A is
universal and present in nearly all tRNAs, which decode
‘ANN’ codons. In all kingdoms of life, the first step of the
biosynthesis of t6A leads to the production of threonyl-
carbamoyl adenylate (TC-AMP), which subsequently is
used to transfer a threonylcarbamoyl group to adenosine.
The enzymes Sua5 and YRDC are responsible for the
formation of TC-AMP in yeast and humans. These homo-
logs belong to the Sua5/TsaC family, function as indepen-
dent monomers and are localized both in the cytoplasm and
mitochondria [54,55,56]. In eukaryotes, the product of
the first reaction step is processed by the cytoplasmic
KEOPS complex, containing five subunits called
OSGEP/Kae1 (catalytic core), PRPK/Bud32, TPRKB/
Cgi121, LAGE3/Pcc1, and C14ORF142/Gon7 [54,57].
Despite some structural knowledge of the Sua5/TsaC
family and the available structures of eukaryotic KEOPS
complex components from yeast, the precise overall assem-
bly of the complex, its mechanism of action as well as the
role of particular subunits in the modification processΨ
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142 Macromolecular assembliesremain poorly understood. The hetero-dimerization of
certain KEOPS subunits andthe presence of a metal cluster
in the active site of catalytic core formed by OSGEP/Kae1
proteins were described [55,56]. The functional roles of
other cascade components are still unknown, although
dimerization of mitochondrial Qri7 seems to be important
for its functionality [56,58]. Despite the fact that detailedFigure 4
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Current Opinion in Structural Biology 2019, 55:138–146 aspects of t6A biosynthesis remain elusive, recent studies
showed that bicarbonate represents a rate-limiting factor
for t6A37 formation (Figure 3). Highlighting its importance,
mutations in t6A synthetase genes are correlated
with neurodegenerative diseases, renal tubulopathy and
Galloway-Mowat syndrome in humans (GAMOS)
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One of the chemically most complex modifications is
catalyzed by a similarly complicated relay system. In
eukaryotes, the highly conserved Elongator complex
[62] carboxymethylates (cm5) 11 out of 13 yeast tRNAs
carrying a U34 in the wobble position [63]. The core
Elongator complex harbors two copies of each of its six
subunits, Elp1-6 and displays an overall molecular weight
of more than 850 kDa [64]. Furthermore, the asymmetri-
cally shaped complex [62] is regulated by various tempo-
rarily associated regulatory factors, including Kti11, Kti12,
Kti13, Kti14/Hrr4, Sit4, Sap185, Sap190, Cbr1, and Mcr1
[65]. In recent years, the crystal structures of the dimeric
Elp1 C-terminus [66], Elp2 [67,68], the enzymatically
active Elp3 subunit [69], the hetero-hexameric Elp456
subcomplex [64], and the temporarily associated regula-
tory factors Kti11, Kti13, and Kti14/Hrr25 [70,71] became
available (Figure 4a). In addition, the overall architecture
of the fully assembled Elongator complex has been
recently determined, using negative stain electron
microscopy in combination with an integrative modeling
approach based on the known high resolution crystal
structures and additional spatial restraints from cross
linking mass spectrometry [67,72].
The pivotal addition of cm5 to U34 can subsequently leads
to the synthesis of 5-methoxycarbonylmethyluridine
(mcm5U), 5-carbamoylmethyluridine (ncm5U), 5-meth-
oxy-carbonyl-methyl-2-thiouridine (mcm5s2U), 5-methox-
ycarbonylmethyl-20-O-methyluridine (mcm5Um), or
5-(carboxyhydroxymethyl)uridine methyl ester (mchm5U)
by otherenzymatic cascades. These small additional groups
on the ‘Elongator’ modification at the fifth carbon (C5)
are attached by Trm9 [73] and Abh8 [74], both of which
require an obligatory activator Trm112 (Figure 1) [74,75,
76]. The identity of the protein that synthesizes ncm5,
either directly or by conversion of mcm5, remains a mystery.
Last but not least, the additional thiolation on the second
carbon (C2) is catalyzed by the Urm1/Uba4 pathway [77],
which in eukaryotes includes Nfs1, Tum1, Urm1, Uba4,
Ncs2, and Ncs6 [78]. In summary, around 25 individual
proteins are involved in wobble uridine modifications,
which are highly conserved among eukaryotes and also
haverelated counterparts inbacteriaandarchaea. It remains
to be shown if some of these factors form dynamic inter-
mediates with the Elongator complex and how they influ-
ence each other.
Conclusion
In summary, tRNA modifiers represent a highly dynamic
network of a large number of macromolecular complexes
and individual proteins. Because of space restrictions, we
are not able to cover structural details regarding the
enzymes that conduct adenine deamination [79], queuo-
sine biosynthesis [80], wybutosine [53], thiolation [78],
and other more unique modifications, like 5-taurino-
methyluridine [81] or N4-acetylcytidine [82].www.sciencedirect.com Nevertheless, we aimed to numerically evaluate the
overall state of the field and compared the number of
known tRNA modifiers in publicly available databases
[83] to other well-established tRNA-dependent mecha-
nisms, like ribosomes and tRNA aminoacyl transferases,
also known as tRNA ligases (Figure 4b). We performed
species-specific queries to more precisely identify the
number of known structures of tRNA modifiers, tRNA
ligases and ribosomes. While the structures of most
ribosomal proteins and more than a half of all human
tRNA ligases have been determined, tRNA modifiers
seem to still offer many possibilities for exploratory
research projects. In particular, RNA-bound or tRNA-
bound structures amount to a relatively small fraction of
available records in the structural databases [84,85].
Undoubtedly, structural characterization of modifiers in
their tRNA-bound state most significantly improves our
understanding of their specificity and catalytic mecha-
nisms. We assume, that the ascent of cryo-EM will have a
similar impact on the tRNA modification field as it had for
the other fields [86].
Interestingly, expansion of tRNA gene copy numbers and
iso-acceptor tRNAs correlate well with an increase in
different tRNA modification enzymes [87]. This obser-
vation suggests co-evolutionary mechanisms, which
expand the decoding potential of the available tRNA
pool and constantly optimize translational efficiency
and accuracy via novel tRNA modification pathways
[87]. Last but not least, the assembly of large complexes
seems advantageous for some modifications, whereas
other pathways seem to rely on stand-alone enzymes.
It remains to be shown, if additional molecular assemblies
that spatially link different modification pathways will be
discovered and characterized.
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